Daclatasviris a medicine used to treat hepatitis c which was approved inEurope in August 2014 for treatment of adults with chronic hepatitis Cgenotypes 1, 2, 3 or 4. Daclatasvir can be used in interferon-free regimens and canalso shorten treatment when added to pegylated interferon and ribavirin.
The treatment ofhepatitis c with Daclatasvir reduces the risk of long-term complications ofhepatitis C such as liver cancer or needing a liver transplant. It is thefirst-ever approved HCV NS5A replication complex inhibitor which interfereswith a protein the virus uses to reproduce and blocks the further growth of thevirus. Import daclatasvir 60mg Tablets from India to China with Shabbir MedicalHall, the most trusted pharmacy.